Grateful to the @ERC_Research for supporting our lab with an #ERCCoG to investigate how environmental cues #IGNITE cancer at the cell, tissue and organismal levels.
Big THANKS to my lab, mentors, colleagues, family (+🐣) and evaluators.
Exciting times ahead! ☀️
@IRBBarcelona
📢 Dr. @DirenaAC receives an @ERC_Research Consolidator Grant to study how #inflammation fuels tumor initiation and evolution.
💡With €2M over the next 5 years, the IGNITE Project will dive deep into #PancreaticCancer to tackle early diagnosis and the development of more efficient treatments.
➡️https://t.co/dVwXwcd77Y
#CancerResearch #ERCconsolidator
🔬 El #cáncer es la primera causa de muerte en muchos países. ¿Pero una mutación maligna en el ADN siempre desencadena un tumor?
🎙️En este podcast de @methub_es, la Dra. @DirenaAC (#IRBBarcelona) y otros investigadores exploran cómo el ambiente y el metabolismo celular también marcan el destino de esta enfermedad.
🎧¡Escúchalo aquí! ▶️ https://t.co/aNwRvshvvp
Immunologists - We are recruiting! My lab @IRBBarcelona is looking for a #postdoc to study the biology and #immunometabolism of dendritic cells & #macrophages in tissues. Check out our website https://t.co/sa4nhOxqkF & email me or apply at https://t.co/ennMZGQ5aN Looking forward!
Excited to share the Way Lab @crick new pre-print. ✨The beauty of combining brains, immunologists and cell biologists at play! Our work uncovers mechanistic insight for immunodeficiency developed under ARPC5 loss of function. https://t.co/Gj5Zr57wdh
🚨🚨🚨🚨
Our new preprint is out!
“Pre-existing stem cell heterogeneity dictates clonal responses to acquisition of cancer driver mutations”
🩸🧫🧪🧬
https://t.co/CYOsKcssPy
The superteam of @cancer_curious and Dani Fernandez tackled a major unanswered question in HSC bio.
1/
Excited to share our piece on how #time shapes macrophage heterogeneity and their functions in bridging #inflammation and #cancer, way before its onset.
Defining "Pre-TAMs" in tumorigenesis and (pre-)malignant evolution
w/ @FGinhoux C. Blériot @DunsmoreGarett@IRBBarcelona 👇🏻
📢📢 Postdoc position available 📢📢
Application deadline June 16th.
Post start date on or after Aug 1st.
Please spread the word or get in touch with me if interested! https://t.co/eIbZmkD0aG
We are recruiting! My lab @IRBBarcelona is looking for a #postdoc and #PhDstudent to work on the biology and metabolism of dendritic cells and macrophages. Check out our website https://t.co/L4k9efobVi & email me or apply at https://t.co/ennMZGPxlf Looking forward meeting you!!!
Lucky to have the best colleague @mccainlab with whom to embark in this new adventure across USC UCLA Caltech, towards controlling tissue organization with synBio and tissue engineering - will be hiring, if you’re interested drop a line!
Super excited to share the first paper from the Puig Saus lab! We have developed a new CAR-T cell therapy for melanoma and are currently working on the clinical translation, exciting times ahead! https://t.co/YFzSGaswYN
In Spring 2024, I will start my own research group at the Randall Centre, @KingsCollegeLon, funded by a @wellcometrust Career Development Award!
This would have been impossible without the support and encouragement of my PhD and postdoc advisors @Mglo & @DrMichaelWay!
Have you ever stared at your cell (or organoid) culture wanting the cells on the right to express gene X, and the cells on the left to express gene Y, and your cells are like
Very excited that our paper on B cells and immunotherapy in lung cancer is out today @Nature . A privilege to work alongside @KevinWNg @EnfieldKatey on this. Give it a read ✨✨
https://t.co/H3vuFM667W
Happy to share my work on the Regulation of branched versus linear Arp2/3‐generated actin filaments. Microfluidics is used here to study the dissociation of Arp2/3 nucleated actin. @Romet_Jegou_lab @DrMichaelWay https://t.co/rr0YELU95h
Finally out! Here we describe the reactivity and clonal evolution of the neoAg-specific T cells over the course of treatment with ICB in patients with melanoma with and without clinical benefit. UCLA and PACT Pharma team effort! @pactpharma@ToniRibas12
https://t.co/yy0OebGXmv